Cargando…

Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia

BACKGROUND: There are no host biomarkers of risk for HIV-associated cryptococcal meningitis (CM) except CD4+ T-cell deficiency. At present, serum cryptococcal antigen (CrAg) screening of those with CD4 <100 cells/µL is used to identify persons at risk for HIV-associated CM. We determined if plasm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hlupeni, Admire, Nakouzi, Antonio, Wang, Tao, Boyd, Kathryn F, Makadzange, Tariro A, Ndhlovu, Chiratidzo E, Pirofski, Liise-anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329905/ https://www.ncbi.nlm.nih.gov/pubmed/30648127 http://dx.doi.org/10.1093/ofid/ofy333

Ejemplares similares

Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease
por: Boyd, Kathryn, et al.
Publicado: (2022)

A Simple Phosphate-Buffered-Saline-Based Extraction Method Improves Specificity of HIV Viral Load Monitoring Using Dried Blood Spots
por: Makadzange, A. Tariro, et al.
Publicado: (2017)

Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia
por: Lehman, Alice, et al.
Publicado: (2023)

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence
por: Oladele, Rita O., et al.
Publicado: (2016)

375. Cryptococcal Antigenemia in Advanced HIV Infection
por: Ahuja, Jatin, et al.
Publicado: (2019)

Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection
por: Makadzange, Azure Tariro, et al.
Publicado: (2016)

Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia
por: Ganiem, Ahmad Rizal, et al.
Publicado: (2014)

Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies
por: Xu, Xiao-Lei, et al.
Publicado: (2020)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
por: Oladele, Rita O., et al.
Publicado: (2023)

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality
por: Letang, Emilio, et al.
Publicado: (2015)

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
por: Montgomery, Martha P., et al.
Publicado: (2017)

Comment on “Cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)”
por: Joob, Beuy, et al.
Publicado: (2012)

Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda
por: Butler, Elissa K., et al.
Publicado: (2012)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
por: Xu, Miaomiao, et al.
Publicado: (2020)

Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study
por: Oyella, Jacinta, et al.
Publicado: (2012)

Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau
por: Thomsen, Ditte, et al.
Publicado: (2018)

Opportunistic Cryptococcal Antigenemia in the HAART Era at HIV Epidemic Settings of Northwest Ethiopia
por: Negash, Markos, et al.
Publicado: (2020)

Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam
por: Smith, Rachel M., et al.
Publicado: (2013)

The transient effect of a peer support intervention to improve adherence among adolescents and young adults failing antiretroviral therapy in Harare, Zimbabwe: a randomized control trial
por: Ndhlovu, Chiratidzo E., et al.
Publicado: (2021)

The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort()
por: Patel, Sheel, et al.
Publicado: (2013)

Response to comment on “Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)”
por: Oyella, Jacinta, et al.
Publicado: (2012)

Unexpected case of cryptococcal meningoencephalitis in a patient with long-standing well-controlled HIV infection
por: Yoon, Hyun ah, et al.
Publicado: (2021)

High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia
por: Alemu, Abere Shiferaw, et al.
Publicado: (2013)

Magnitude of Cryptococcal Antigenemia among HIV Infected Patients at a Referral Hospital, Northwest Ethiopia
por: Derbie, Awoke, et al.
Publicado: (2018)

Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
por: Huang, Sung-Hsi, et al.
Publicado: (2021)

Prior Pulmonary Tuberculosis Is a Risk Factor for Asymptomatic Cryptococcal Antigenemia in a Cohort of Adults With Advanced Human Immunodeficiency Virus Disease
por: Wake, Rachel M, et al.
Publicado: (2022)

Vaccine Adverse Events Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe
por: Makadzange, Azure Tariro, et al.
Publicado: (2022)

Investigating Attitudes, Motivations and Key Influencers for COVID-19 Vaccination Uptake among Late Adopters in Urban Zimbabwe
por: Makadzange, Azure Tariro, et al.
Publicado: (2023)

Prevalence of Advanced HIV Disease, Cryptococcal Antigenemia, and Suboptimal Clinical Outcomes Among Those Enrolled in Care in Vietnam
por: Dat, Vu Quoc, et al.
Publicado: (2021)

Cryptococcus neoformans–Specific and Non–Cryptococcus neoformans–Specific Antibody Profiles in Organ Transplant Recipients With and Without Cryptococcosis
por: Yoon, Hyunah, et al.
Publicado: (2022)

Fc Gamma Receptor 3A Polymorphism and Risk for HIV-Associated Cryptococcal Disease
por: Rohatgi, Soma, et al.
Publicado: (2013)

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications
por: Wake, Rachel M, et al.
Publicado: (2022)

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection( )
por: Verkerke, Hans P, et al.
Publicado: (2022)

Failure of Early Mycological Clearance in HIV-Negative Cryptococcal Meningitis
por: Su, Zhihui, et al.
Publicado: (2023)

Attitudes to Vaccine Mandates among Late Adopters of COVID-19 Vaccines in Zimbabwe
por: Makadzange, Azure Tariro, et al.
Publicado: (2022)

Cryptococcal Antigen Screening and Missed Opportunities for Earlier Diagnosis Among People With HIV and Poor Virologic Control in the Bronx, NY
por: Yoon, Hyunah, et al.
Publicado: (2022)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review
por: Derbie, Awoke, et al.
Publicado: (2020)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia
por: Smitson, Christopher C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c1isjpipoo9p0jqrq1inrgfjr4